New agreement on hospital pharma prices in Denmark

In Denmark, the Ministry of Health and Prevention, the Danish Regions and the Danish Association of the Pharmaceutical Industry (Lif) have reached an agreement on price reductions and caps on the prices of hospital-only medicines in Denmark between April 1, 2016, and March 31, 2019.

It is the third time that agreements have been reached for price-caps and price reductions for medicine for use in the country's hospitals. This agreement sees the reduction of the previously agreed price-caps for individual medicines by a total of 10% during the term of the agreement. The price-caps are to be reduced by 2.5% on May 1, 2016, by 2.5% on April 1, 2017, by 2.5 % on April 1, 2018 and 2.5 % on February 1, 2019.

The price-cap agreement aims to ensure predictability and that the level of list prices for hospital medicine in Denmark is in line with prices in line with comparable countries: Sweden, Norway, Finland, the UK, Netherlands, Belgium, Germany, Ireland and Austria. The agreed price-cap reductions totaling 10% will be made so as to reduce the list prices of hospital medicines in Denmark and the pricing trends in the comparable countries are also expected to decline.